Comparison of Surveillance Colonoscopy Techniques in Patients With IBD
NCT ID: NCT02098798
Last Updated: 2016-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
270 participants
OBSERVATIONAL
2014-03-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesized that these novel endoscopic techniques using High definition colonoscopy with virtual chromoendoscopy -iScan 2 and 3 may be superior to high definition colonoscopy alone and similar to using dye spraying chromoendoscopy for detection of dysplasia and neoplasia in patients with long standing IBD.
We will aim to demonstrate if we can avoid dye spraying during the procedure and save expense and considerable time.
In addition, we can hope to produce evidence and inform the way in which we perform surveillance colonoscopy especially without large number of multiple random biopsies but only few targeted" smart and intelligent" biopsies using high definition colonoscopy with iSCAN technique as is already the European practice in several centres.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Chromoendoscopy for Colitis Surveillance: A Feasibility Study
NCT02543021
The Use of Magnetic Endoscopic Imaging for Improving Quality Indicators in Outpatient Colonoscopy
NCT01480830
A Prospective Study of the Effect of Modified Colonoscopy Bowel Preparation Program on Intestinal Cleaning, Examination and Disease in Patients With Inflammatory Bowel Disease
NCT05485103
Water-aided Colonoscopy in Inflammatory Bowel Disease Patients
NCT01933867
Outcome of Colonoscopy Screening and Surveillance
NCT01827241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HD
High Definition Colonoscopy alone
HD Colonoscopy
High definition colonoscopy procedure in surveillance colonoscopy
HD + iSCAN
HD colonoscopy + iSCAN
HD Colonoscopy + iSCAN
HD + Dye
High definition colonoscopy + dye spraying chromoendoscopy
HD Colonoscopy + dye spray
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HD Colonoscopy
High definition colonoscopy procedure in surveillance colonoscopy
HD Colonoscopy + iSCAN
HD Colonoscopy + dye spray
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
UC -CD Disease duration 8 years from diagnosis UC-CD with associated primary sclerosing cholangitis from diagnosis Ulcerative Colitis Activity Index Mayo score 0-1 (inactive disease) Crohn's disease Activity Index - Harvey Bradshaw score \<4 (dysplasia detection requires quiescent inflammatory bowel disease)
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iacucci Marietta MD,PhD
Clinical Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Calgary, Foothills Medical Centre
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB13-0960
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.